Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
Treatments Tackle Maladies From Fleas to ‘Cognitive Dysfunction’
CHICAGO–Pfizer is spending an estimated $10 million to launch its latest product, a drug that offers “new hope” for aging patients and those who love them.
The campaign from Colle & McVoy, Minneapolis, is comprised of print, direct mail and broadcast and cable TV ads. But the patient aided by Pfizer’s new drug isn’t a person.
It’s the family dog.
Anipryl, which treats canine Cognitive Dysfunction Syndrome, is the Exton, Pa.,
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in